Lista de obras - Ricardo Caballero - Dominio Público Uruguay

Assembly with the Kvbeta1.3 subunit modulates drug block of hKv1.5 channels

artículo científico publicado en 2002

Association of 14-3-3 proteins to beta1-adrenergic receptors modulates Kv11.1 K+ channel activity in recombinant systems.

artículo científico publicado en 2006

Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5).

artículo científico publicado en 1999

Cancer chemotherapy and cardiac arrhythmias: a review.

artículo científico publicado en 2015

Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations

artículo científico publicado en 2016

Cardiac electrophysiological effects of nitric oxide.

artículo científico publicado en 2010

Chronic atrial fibrillation increases microRNA-21 in human atrial myocytes decreasing L-type calcium current

artículo científico publicado en 2014

Chronic atrial fibrillation up-regulates β1-Adrenoceptors affecting repolarizing currents and action potential duration

artículo científico publicado en 2012

Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations

artículo científico publicado en 2004

Dronedarone

artículo científico publicado en 2011

Drug-induced atrial fibrillation

artículo científico publicado en 2012

Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5.

artículo científico publicado en 1997

Effects of atorvastatin and simvastatin on atrial plateau currents.

artículo científico publicado en 2007

Effects of flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines.

artículo científico publicado en 2003

Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization

artículo científico publicado en 2003

Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block

artículo científico publicado en 2002

Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels

artículo científico publicado en 1998

Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels

artículo científico publicado en 2003

Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels

artículo científico publicado en 1999

Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.

artículo científico publicado en 2010

Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.

artículo científico publicado en 2009

Functional characterization of a novel frameshift mutation in the C-terminus of the Nav1.5 channel underlying a Brugada syndrome with variable expression in a Spanish family

artículo científico publicado en 2013

Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome.

artículo científico publicado en 2010

In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both

artículo científico publicado en 2010

Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current

artículo científico publicado en 2004

Investigational positive inotropic agents for acute heart failure.

artículo científico publicado en 2009

Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy.

artículo científico publicado en 2006

Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels

artículo científico publicado en 2016

New investigational drugs for the management of acute heart failure syndromes.

artículo científico publicado en 2010

Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism.

artículo científico publicado en 2006

Nitric oxide increases cardiac IK1 by nitrosylation of cysteine 76 of Kir2.1 channels.

artículo científico publicado en 2009

Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1).

artículo científico publicado en 2008

Pharmacological Approaches in the Treatment of Atrial Fibrillation

artículo científico publicado en 2004

Pharmacology of cardiac potassium channels.

artículo científico publicado en 2004

Pitx2c increases in atrial myocytes from chronic atrial fibrillation patients enhancing IKs and decreasing ICa,L.

artículo científico publicado en 2015

Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore.

artículo científico publicado en 2013

Regulation of SCN5A by microRNAs: miR-219 modulates SCN5A transcript expression and the effects of flecainide intoxication in mice.

artículo científico publicado en 2015

Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels

artículo científico publicado en 2003

Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents.

artículo científico publicado en 2014

Tbx20 controls the expression of the KCNH2 gene and of hERG channels

artículo científico publicado en 2017

The safety of digoxin as a pharmacological treatment of atrial fibrillation.

artículo científico publicado en 2006

miR-208b upregulation interferes with calcium handling in HL-1 atrial myocytes: Implications in human chronic atrial fibrillation

artículo científico publicado en 2016

Lista de obras de Ricardo Caballero

Assembly with the Kvbeta1.3 subunit modulates drug block of hKv1.5 channels

Association of 14-3-3 proteins to beta1-adrenergic receptors modulates Kv11.1 K+ channel activity in recombinant systems.

Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5).

Cancer chemotherapy and cardiac arrhythmias: a review.

Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations

Cardiac electrophysiological effects of nitric oxide.

Chronic atrial fibrillation increases microRNA-21 in human atrial myocytes decreasing L-type calcium current

Chronic atrial fibrillation up-regulates β1-Adrenoceptors affecting repolarizing currents and action potential duration

Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations

Dronedarone

Drug-induced atrial fibrillation

Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5.

Effects of atorvastatin and simvastatin on atrial plateau currents.

Effects of flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines.

Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization

Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block

Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels

Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels

Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels

Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.

Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.

Functional characterization of a novel frameshift mutation in the C-terminus of the Nav1.5 channel underlying a Brugada syndrome with variable expression in a Spanish family

Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome.

In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both

Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current

Investigational positive inotropic agents for acute heart failure.

Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy.

Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels

New investigational drugs for the management of acute heart failure syndromes.

Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism.

Nitric oxide increases cardiac IK1 by nitrosylation of cysteine 76 of Kir2.1 channels.

Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1).

Pharmacological Approaches in the Treatment of Atrial Fibrillation

Pharmacology of cardiac potassium channels.

Pitx2c increases in atrial myocytes from chronic atrial fibrillation patients enhancing IKs and decreasing ICa,L.

Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore.

Regulation of SCN5A by microRNAs: miR-219 modulates SCN5A transcript expression and the effects of flecainide intoxication in mice.

Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels

Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents.

Tbx20 controls the expression of the KCNH2 gene and of hERG channels

The safety of digoxin as a pharmacological treatment of atrial fibrillation.

miR-208b upregulation interferes with calcium handling in HL-1 atrial myocytes: Implications in human chronic atrial fibrillation